心脏病的治疗靶点与个性化医疗
Therapeutic Targets and Personalized Medicine in Cardiac Disease.
作者信息
Vafiadaki Elizabeth, Turnbull Irene C, Sanoudou Despina
机构信息
Center of Basic Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
出版信息
J Pers Med. 2023 Oct 26;13(11):1534. doi: 10.3390/jpm13111534.
Abstract
Despite extensive research that has achieved notable advancements over the last decades, cardiovascular disease (CVD) remains the leading cause of death worldwide, with millions affected around the world [...].
摘要
尽管在过去几十年里进行了广泛研究并取得了显著进展，但心血管疾病（CVD）仍然是全球主要死因，全球数以百万计的人受到影响[...]。
相似文献
1
Therapeutic Targets and Personalized Medicine in Cardiac Disease.
J Pers Med. 2023 Oct 26;13(11):1534. doi: 10.3390/jpm13111534.
2
Revolutionizing Cardiac Care: A Comprehensive Narrative Review of Cardiac Rehabilitation and the Evolution of Cardiovascular Medicine.
Cureus. 2023 Oct 4;15(10):e46469. doi: 10.7759/cureus.46469. eCollection 2023 Oct.
3
Traditional Chinese medicine and mitophagy: A novel approach for cardiovascular disease management.
Phytomedicine. 2024 Jun;128:155472. doi: 10.1016/j.phymed.2024.155472. Epub 2024 Feb 24.
4
A utility-based machine learning-driven personalized lifestyle recommendation for cardiovascular disease prevention.
J Biomed Inform. 2023 May;141:104342. doi: 10.1016/j.jbi.2023.104342. Epub 2023 Mar 22.
5
Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.
Front Med (Lausanne). 2019 Sep 13;6:202. doi: 10.3389/fmed.2019.00202. eCollection 2019.
6
Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease.
Curr Probl Cardiol. 2024 Jan;49(1 Pt C):102182. doi: 10.1016/j.cpcardiol.2023.102182. Epub 2023 Oct 30.
7
Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Curr Pharm Biotechnol. 2017;18(3):231-241. doi: 10.2174/1389201018666170123153626.
8
Genomic medicine in the prevention and treatment of atherosclerotic cardiovascular disease.
Per Med. 2012 Jun;9(4):395-404. doi: 10.2217/pme.12.34.
9
Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Clin Genet. 2017 Mar;91(3):355-370. doi: 10.1111/cge.12881. Epub 2016 Nov 30.
10
The changing face of cardiovascular disease 2000-2012: An analysis of the world health organisation global health estimates data.
Int J Cardiol. 2016 Dec 1;224:256-264. doi: 10.1016/j.ijcard.2016.09.026. Epub 2016 Sep 15.
引用本文的文献
1
Etiology, Pathophysiology, and Treatment Strategies in the Prevention and Management of Metabolic Syndrome.
Arch Intern Med Res. 2024;7(4):273-283. doi: 10.26502/aimr.0184. Epub 2024 Oct 28.
本文引用的文献
1
Evolving cardiovascular genetic counseling needs in the era of precision medicine.
Front Cardiovasc Med. 2023 Jun 23;10:1161029. doi: 10.3389/fcvm.2023.1161029. eCollection 2023.
2
Phospholamban R14del disease: The past, the present and the future.
Front Cardiovasc Med. 2023 Apr 18;10:1162205. doi: 10.3389/fcvm.2023.1162205. eCollection 2023.
3
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts.
Metabolism. 2023 Jan;138:155344. doi: 10.1016/j.metabol.2022.155344. Epub 2022 Nov 12.
4
The Challenge and Importance of Integrating Drug-Nutrient-Genome Interactions in Personalized Cardiovascular Healthcare.
J Pers Med. 2022 Mar 22;12(4):513. doi: 10.3390/jpm12040513.
5
Precision Medicine in Aortic Anastomosis: A Numerical and Experimental Study of a Novel Double-Sided Needle.
J Pers Med. 2021 Dec 20;11(12):1385. doi: 10.3390/jpm11121385.
6
The Potential of Hsp90 in Targeting Pathological Pathways in Cardiac Diseases.
J Pers Med. 2021 Dec 16;11(12):1373. doi: 10.3390/jpm11121373.
7
The Potential of Gamma Secretase as a Therapeutic Target for Cardiac Diseases.
J Pers Med. 2021 Dec 4;11(12):1294. doi: 10.3390/jpm11121294.
8
Impaired Right Ventricular Calcium Cycling Is an Early Risk Factor in R14del-Phospholamban Arrhythmias.
J Pers Med. 2021 Jun 3;11(6):502. doi: 10.3390/jpm11060502.
9
Creating a 'Molecular Band-Aid'; Blocking an Exposed Protease Target Site in Desmoplakin.
J Pers Med. 2021 May 12;11(5):401. doi: 10.3390/jpm11050401.
10
Advances in biological therapies for dyslipidemias and atherosclerosis.
Metabolism. 2021 Mar;116:154461. doi: 10.1016/j.metabol.2020.154461. Epub 2020 Dec 5.
Zotero 插件